Advertisement

Ads Placeholder
Loading...

DENTSPLY SIRONA Inc.

DY2.DEXETRA
Healthcare
Medical - Equipment & Services
17.77
0.09(0.54%)
German Market opens in 7h 7m

DENTSPLY SIRONA Inc. Fundamental Analysis

DENTSPLY SIRONA Inc. (DY2.DE) shows weak financial fundamentals with a PE ratio of -8.14, profit margin of -17.53%, and ROE of -24.18%. The company generates $2.6B in annual revenue with weak year-over-year growth of -4.34%.

Key Strengths

Current Ratio1.69

Areas of Concern

ROE-24.18%
Operating Margin8.00%
PEG Ratio2.02
We analyze DY2.DE's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -25.7/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-25.7/100

We analyze DY2.DE's fundamental strength across five key dimensions:

Efficiency Score

Weak

DY2.DE struggles to generate sufficient returns from assets.

ROA > 10%
-8.44%

Valuation Score

Moderate

DY2.DE shows balanced valuation metrics.

PE < 25
-8.14
PEG Ratio < 2
2.02

Growth Score

Weak

DY2.DE faces weak or negative growth trends.

Revenue Growth > 5%
-4.34%
EPS Growth > 10%
-6.23%

Financial Health Score

Moderate

DY2.DE shows balanced financial health with some risks.

Debt/Equity < 1
1.27
Current Ratio > 1
1.69

Profitability Score

Weak

DY2.DE struggles to sustain strong margins.

ROE > 15%
-2418.16%
Net Margin ≥ 15%
-17.53%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is DY2.DE Expensive or Cheap?

P/E Ratio

DY2.DE trades at -8.14 times earnings. This suggests potential undervaluation.

-8.14

PEG Ratio

When adjusting for growth, DY2.DE's PEG of 2.02 indicates potential overvaluation.

2.02

Price to Book

The market values DENTSPLY SIRONA Inc. at 2.13 times its book value. This may indicate undervaluation.

2.13

EV/EBITDA

Enterprise value stands at -6.13 times EBITDA. This is generally considered low.

-6.13

How Well Does DY2.DE Make Money?

Net Profit Margin

For every $100 in sales, DENTSPLY SIRONA Inc. keeps $-17.53 as profit after all expenses.

-17.53%

Operating Margin

Core operations generate 8.00 in profit for every $100 in revenue, before interest and taxes.

8.00%

ROE

Management delivers $-24.18 in profit for every $100 of shareholder equity.

-24.18%

ROA

DENTSPLY SIRONA Inc. generates $-8.44 in profit for every $100 in assets, demonstrating efficient asset deployment.

-8.44%

Following the Money - Real Cash Generation

Operating Cash Flow

DENTSPLY SIRONA Inc. generates limited operating cash flow of $139.53M, signaling weaker underlying cash strength.

$139.53M

Free Cash Flow

DENTSPLY SIRONA Inc. generates weak or negative free cash flow of $39.61M, restricting financial flexibility.

$39.61M

FCF Per Share

Each share generates $0.19 in free cash annually.

$0.19

FCF Yield

DY2.DE converts 0.99% of its market value into free cash.

0.99%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-8.14

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

2.02

vs 25 benchmark

P/B Ratio

Price to book value ratio

2.13

vs 25 benchmark

P/S Ratio

Price to sales ratio

1.52

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

1.27

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.69

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.24

vs 25 benchmark

ROA

Return on assets percentage

-0.08

vs 25 benchmark

ROCE

Return on capital employed

0.05

vs 25 benchmark

How DY2.DE Stacks Against Its Sector Peers

MetricDY2.DE ValueSector AveragePerformance
P/E Ratio-8.1428.03 Better (Cheaper)
ROE-24.18%734.00% Weak
Net Margin-17.53%-46943.00% (disorted) Weak
Debt/Equity1.270.35 Weak (High Leverage)
Current Ratio1.692778.18 Neutral
ROA-8.44%-17472.00% (disorted) Weak

DY2.DE outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews DENTSPLY SIRONA Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

3.36%

Industry Style: Defensive, Growth, Innovation

Growing

EPS CAGR

-480.04%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-20.01%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ